Myocardial Ischemia
📧 Sign up to get email alerts when something new happens for Myocardial Ischemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Gene Therapy for the Treatment of Chronic Stable Angina [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial for chronic stable angina (myocardial ischemia) sponsored by Helixmith was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-17Clinical Trial Update: Pre-conditioning by Balloon-inflation on Myocardial Injury [NA]
A clinical trial evaluating balloon-inflation pre-conditioning to reduce myocardial injury in myocardial ischemia has been withdrawn. No fur…
-
CLINICAL_TRIALS withdrawal · 2024-05-17Clinical Trial Update: Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction [Phase 3]
Phase 3 trial evaluating adenosine's effect on resolution of myocardial stunning after acute myocardial infarction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-03-13Clinical Trial Update: Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries [Phase 4]
Phase 4 trial evaluating ranolazine for myocardial ischemia in patients with chronic total occlusions was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-09-22Clinical Trial Update: Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization [Phase 3]
Phase 3 trial of adipose stromal cell injection in the myocardium for revascularization was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-17Clinical Trial Update: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers [Phase 1]
Phase 1 safety study of intravenous thymosin beta in healthy volunteers sponsored by RegeneRx Biopharmaceuticals has been withdrawn; the tri…
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Beta-blocker Before Extubation [NA]
A clinical trial investigating the use of a beta-blocker before extubation in patients with myocardial ischemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-29Clinical Trial Update: The eSVS® Mesh Post-Marketing Trial [NA]
The post-marketing trial of the eSVS Mesh has been terminated.
-
CLINICAL_TRIALS withdrawal · 2016-01-06Clinical Trial Update: Training Levels Comparison Trial
A University of Alabama at Birmingham clinical trial named 'Training Levels Comparison Trial' has been withdrawn. The study is no longer act…
-
CLINICAL_TRIALS withdrawal · 2014-06-09Clinical Trial Update: Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) [Phase 3]
A Phase 3 trial evaluating vorapaxar for prevention of heart attack and stroke in acute coronary syndrome was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-02-28Clinical Trial Update: The eSVS® Mesh Randomized Post-Market Study [NA]
The eSVS Mesh randomized post-market study sponsored by Kips Bay Medical, Inc. was terminated.
-
CLINICAL_TRIALS withdrawal · 2012-02-17Clinical Trial Update: Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
A clinical trial comparing left ventricular volume and wall stress using dobutamine versus exercise echocardiography has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-09-14Clinical Trial Update: Stem Cell Study for Patients With Heart Failure [Phase 2]
A Phase 2 stem cell trial for heart failure/ischemia has been withdrawn.